Market Tracker

11/21 6:05pm ET

Aegerion Pharmaceuticals Inc (NASDAQ:AEGR)

21.37
Data as of Nov 21
 +0.42 / +2.00%
Today’s Change
19.10
Today|||52-Week Range
74.58
-69.88%
Year-to-Date

Today’s Trading

Previous close20.95
Today’s open21.23
Day’s range20.89 - 21.44
Volume548,766
Average volume (3 months)1,352,312
Market cap$607.7M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+17.05%
Earnings growth (this year)+49.94%
Earnings growth (next 5 years)+15.96%
Revenue growth (last year)--
P/E ratioNM
Price/Sales42.22
Price/Book5.56

Competitors

 Today’s
change
Today’s
% change
MNTAMomenta Pharmaceutic...+0.19+1.68%
ESPREsperion Therapeutic...+0.39+1.33%
AERIAerie Pharmaceutical...+0.05+0.20%
OVASOvaScience Inc+0.18+0.74%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$48.5M
Annual profit (last year)-$63.4M
Net profit margin-130.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Marc D. Beer
Chief Operating Officer
Craig E. Fraser
Corporate headquarters
Cambridge, Massachusetts

Forecasts